Juan Diaz‐Cartelle

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial

William A. Gray, Koen Keirse, Yoshimitsu Soga et al. · The Lancet · 2018 · 279 citations

Zilver Ptx, Paclitaxel-eluting Stent, Endovascular Technique +8

12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment

Sabine Steiner, Andrea Willfort‐Ehringer, Horst Sievert et al. · JACC: Cardiovascular Interventions · 2018 · 99 citations · Full text

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease

Stefan Müller‐Hülsbeck, Koen Keirse, Thomas Zeller et al. · Journal of Endovascular Therapy · 2016 · 97 citations · Full text

Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial

Yann Gouëffic, Giovanni Torsello, Thomas Zeller et al. · Circulation · 2022 · 95 citations · Full text

Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent

Stefan Müller‐Hülsbeck, Andrew Benko, Yoshimitsu Soga et al. · CardioVascular and Interventional Radiology · 2020 · 92 citations

Cardiovascular Disease, Imperial Randomized Study, Vascular Surgery +7